The idea that NK cells can distinguish aberrant cells by recognizing 'absence of the expected', rather than 'presence of the unexpected' emerged more than 25 years ago. Klas Kärre recapitulates how the idea took shape, and the first five years of experimental work to test its general predictions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kiessling, R., Klein, E. & Wigzell, H. 'Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cell. Specificity and distribution according to genotype. Eur. J. Immunol. 5, 112–117 (1975).
Herberman, R.B., Nunn, M.E. & Lavrin, D.H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16, 216–223 (1975).
Snell, G. Histocompatibility genes of the mouse. II. Production and analysis of isogenic-resistant lines. J. Natl. Cancer Inst. 21, 843–877 (1958).
Cudkowicz, G. & Bennet, M. Peculiar immunobiology of bone marrow allografts. I. Rejection of parental grafts by resistant F1 hybrid mice. J. Exp. Med. 134, 1513–1528 (1971).
Kiessling, R. et al. Evidence for a similar or common mechanism for natural killer activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7, 655–664 (1977).
Kiessling, R., Petranyi, G., Klein, G. & Wigzell, H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of nonimmunized semisyngeneic mice against a mouse lymphoma line. Int. J. Cancer 15, 933–944 (1975).
Welsh, R.M., Karre, K., Hansson, M., Kunkel, L.A. & Kiessling, R.W. Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells. J. Immunol. 126, 219–225 (1981).
Stern, P., Gidlund, M., Örn, A. & Wigzell, H. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC. Nature 285, 341–342 (1980).
Snell, G. Recognition structures determined by the H-2 complex. Transplant. Proc. 8, 147–152 (1976).
De Baetselier, P., Katzav, S., Gorelik, E., Feldman, M. & Segal, S. Differential expression of H-2 gene products in tumour cells is associated with their metastatogenic properties. Nature 288, 179–181 (1980).
Hildemann, W.H. Specific immunorecognition by histocompatibility markers: the original polymorphic system of immunoreactivity characteristic of all multicellular animals. Immunogenetics 5, 193–202 (1977).
Kolb, H. On the phylogenetic origin of the immune system – a hypothesis. Dev. Comp. Immunol. 1, 193–206 (1977).
Scofeld, V.L. & Weissman, I.L. Allorecognition in biological systems. Dev. Comp. Immunol. 5, 23–28 (1981).
De Tomaso, A.W. et al. Isolation and characterization of a protochordate histocompatibility locus. Nature 438, 454–459 (2005).
Kärre, K. How to recognize a foreign submarine. Immunol. Rev. 155, 5–9 (1997).
Kärre, K. On the Immunobiology of Natural Killer Cells. Doctoral thesis, Karolinska Institute (1981).
Kärre, K. Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis. in Mechanisms of Cytotoxicity by NK Cells (eds. Callewaert, D. & Herberman, R.B.) 81–91 (Academic, San Diego, 1985).
Ljunggren, H.G. & Kärre, K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11, 237–241 (1990).
Ljunggren, H.G. & Kärre, K. Host resistance directed selectively against H-2 deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162, 1745–1753 (1985).
Kärre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
Piontek, G. et al. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression following IFN treatment or in vivo passage. J. Immunol. 135, 4281–4288 (1985).
Taniguchi, K. et al. Interferon γ induces lung colonization by intravenously inoculated B 16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Proc. Natl. Acad. Sci. USA 84, 3405–3409 (1987).
Höglund, P. et al. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57Bl mice. J. Exp. Med. 168, 1469–1474 (1988).
Öhlén, C. et al. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246, 666–668 (1989).
Quillet, A. et al. Increased resistance to non-MHC-restricted cytotoxicity related to HLA-A, B expression. Direct demonstration using β2-microglobulin-transfected Daudi cells. J. Immunol. 141, 17–28 (1988).
Storkus, W.J., Alexander, J., Payne, J.A., Dawson, J.R. & Cresswell, P. Reversal of natural killing susceptibility in target cells expressing transfected class I genes. Proc. Natl. Acad. Sci. USA 86, 2361–2364 (1989).
Kärre, K. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55, 221–228 (2002).
Kärre, K. MHC gene control of the natural killer system at the level of the target and the host. Semin. Cancer Biol. 2, 295–309 (1991).
Acknowledgements
My work has been supported by Karolinska Institute, the Swedish Cancer Society, the Swedish Research Council, the Swedish Foundation for Strategic Research, the Göran Gustafsson Foundation and the European Molecular Biology Organization. I thank all collaborators in the past and present: graduate students, undergraduate students, postdoctoral fellows, mentors and collaborators in other groups in many different countries, especially R. Kiessling, H.-G. Ljunggren, G. Klein, P. Höglund and C. Öhlén.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kärre, K. Natural killer cell recognition of missing self. Nat Immunol 9, 477–480 (2008). https://doi.org/10.1038/ni0508-477
Issue Date:
DOI: https://doi.org/10.1038/ni0508-477
This article is cited by
-
Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Virology Journal (2024)
-
Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
BMC Immunology (2023)
-
Defining the role of natural killer cells in COVID-19
Nature Immunology (2023)
-
Altered Signatures of Plasma Inflammatory Proteins and Phonotypic Markers of NK Cells in Kidney Transplant Patients upon CMV Reactivation
Current Microbiology (2023)
-
Natural killer cells: a promising immunotherapy for cancer
Journal of Translational Medicine (2022)